Thalidomide: tragic past and promising future.
Rajkumar
S Vincent
SV
Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA. rajks@mayo.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009101:Multiple Myeloma / Q000188:drug therapy*; D011247:Pregnancy; D013723:Teratogens / Q000633:toxicity*; D013792:Thalidomide / Q000627:therapeutic use* / Q000633:toxicity*
D020533:Angiogenesis Inhibitors; D013723:Teratogens; D013792:Thalidomide